A retrospective analysis of post-stroke rehabilitation with real world use of brain-computer interface.
Neha K Prasad, Nikhita J Perry, Allison L Goldring and 5 others
PMID 41566501WHAT IT FOUND
Most chronic stroke survivors with severe upper limb weakness improved enough on a motor scale to be considered clinically meaningful after using a brain-computer interface hand device.
Improvement often happened within 12 weeks, though some needed longer. This was uncontrolled real-world data, so it does not prove the device caused the gains.
Key findings
0170% of the analyzed patients achieved a clinically meaningful improvement in upper limb motor function by 55 weeks, with 64% achieving it within 12 weeks.
02The majority of patients (82%) had severe motor impairment at baseline, and one-third of this group transitioned to a lower severity classification during therapy.
03Patients who did not show improvement by 12 weeks still had the potential to achieve clinically meaningful gains during extended use up to 55 weeks.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
No control group was used; patients served as their own baselines, making it impossible to distinguish device effects from spontaneous recovery, placebo, or the effects of increased movement practice alone. Real-world data was incomplete, leading to the exclusion of 22 patients due to missing or ambiguous UEFM scores, which may introduce selection bias. Device adherence was not monitored or enforced, so it is unclear how much therapy time contributed to the outcomes. The MCID threshold of 5.25 points was derived from subacute stroke populations with milder impairments, which may not be appropriate for the severe chronic population studied here. The study relied on virtual assessments of the UEFM, including inferred reflex status, which may differ in sensitivity from in-person clinical examination.
Declared interests
The data was collected and maintained by the manufacturer's team for quality assurance purposes. The study used de-identified patient data provided by the manufacturer.
The easy way to misread this
Do not interpret the 70% improvement rate as evidence that the IpsiHand system causes motor recovery. This was an uncontrolled retrospective study where patients received only the device and its associated movement practice. Improvements may be due to the intensity of therapy, natural variability, or other concurrent factors, not specifically the brain-computer interface mechanism.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →